Vireo Growth (VREOF) Other Non Operating Income (2020 - 2026)
Vireo Growth's (VREOF) quarterly Other Non Operating Income came in at $100000.0 in Q1 2026, down 87.5% year-on-year from $800000.0 in Q1 2025, and up 106.5% quarter-over-quarter from -$1.5 million in Q4 2025.
Vireo Growth (VREOF) Other Non Operating Income (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Other Non Operating Income across 7 years of filings, most recently posting $100000.0 for Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $100000.0, down 87.5% year-over-year; the trailing twelve-month figure through Mar 2026 was -$862849.0 (down 299.87% YoY), and the FY2025 annual result was -$172811.0, down 118.2% from the prior year.
- Other Non Operating Income came in at $100000.0 for Q1 2026 at Vireo Growth, up from -$1.5 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $5.8 million in Q2 2023 to a low of -$2.9 million in Q4 2024.
- The 5-year median for Other Non Operating Income is $345824.0 (2023), against an average of $580896.5.
- Across the five-year window, Other Non Operating Income soared 7105.44% in 2023 and tumbled 285.63% in 2024, its largest moves.
- Vireo Growth's Other Non Operating Income stood at $45518.0 in 2022, then jumped by 3370.77% to $1.6 million in 2023, then sank by 285.63% to -$2.9 million in 2024, then jumped by 47.55% to -$1.5 million in 2025, then soared by 106.5% to $100000.0 in 2026.
- The last three Other Non Operating Income figures came in at $100000.0 (Q1 2026), -$1.5 million (Q4 2025), and $983080.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | -1.54 Mn |
| Sep 30, 2025 | 983,080.00 |
| Jun 30, 2025 | -407,673.00 |
| Mar 31, 2025 | 800,000.00 |
| Dec 31, 2024 | -2.93 Mn |
| Sep 30, 2024 | 970,850.00 |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 1.32 Mn |
| Dec 31, 2023 | 1.58 Mn |
| Sep 30, 2023 | 345,824.00 |
| Jun 30, 2023 | 5.80 Mn |
| Mar 31, 2023 | 22,313.00 |
| Dec 31, 2022 | 45,518.00 |
| Sep 30, 2022 | 79,750.00 |
| Jun 30, 2022 | -82,769.00 |
| Mar 31, 2022 | 1.20 Mn |
| Dec 31, 2021 | -278,260.00 |
| Sep 30, 2021 | 75,018.00 |
| Jun 30, 2021 | -98,055.00 |